Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia.

Ando S, Kanazawa M, Onodera O.

J Mov Disord. 2020 Jan;13(1):20-26. doi: 10.14802/jmd.19061. Epub 2019 Dec 19.

Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.

Mollá B, Muñoz-Lasso DC, Calap P, Fernandez-Vilata A, de la Iglesia-Vaya M, Pallardó FV, Moltó MD, Palau F, Gonzalez-Cabo P.

Neurotherapeutics. 2019 Feb 13. doi: 10.1007/s13311-018-00706-z. [Epub ahead of print]

[Recurrent ataxia and respiratory failure with probable paraneoplastic syndrome responsive to plasma exchange therapy].

Kondo T, Igari R, Sato H, Iseki C, Ishizawa K, Suzuki K.

Rinsho Shinkeigaku. 2019 May 29. doi: 10.5692/clinicalneurol.cn-001234. [Epub ahead of print] Japanese.

Late-Onset Friedreich's Ataxia (LOFA) Mimicking Charcot-Marie-Tooth Disease Type 2: What Is Similar and What Is Different?

Salomão RP, Gama MT, Rezende Filho FM, Maggi F, Pedroso JL, Barsottini OG.

Cerebellum. 2016 Sep 29. [Epub ahead of print]

Spinocerebellar ataxia type 10: from Amerindians to Latin Americans.

Teive HA, Ashizawa T.

Curr Neurol Neurosci Rep. 2013 Nov;13(11):393. doi: 10.1007/s11910-013-0393-9. No abstract available.

[Fragile X-associated tremor/ataxia syndrome].

Han WW, Zhang L, Jiang H, Tang BS.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Feb;28(1):52-5. doi: 10.3760/cma.j.issn.1003-9406.2011.01.012. Review. Chinese.

[Opsoclonus myoclonus ataxia syndrome in Israel].

Blumkin L, Lerman-Sagie T.

Harefuah. 2010 Jan;149(1):24-8, 63. Hebrew.

Report of progressive myoclonus ataxia (PMA) in two Chinese pedigrees.

Sun L, Wu J, Liu C, Lin W.

Neurol Res. 2016 Oct;38(10):893-6. doi: 10.1080/01616412.2016.1199297.

Genetic Variants Associated with Episodic Ataxia in Korea.

Choi KD, Kim JS, Kim HJ, Jung I, Jeong SH, Lee SH, Kim DU, Kim SH, Choi SY, Shin JH, Kim DS, Park KP, Kim HS, Choi JH.

Sci Rep. 2017 Oct 23;7(1):13855. doi: 10.1038/s41598-017-14254-7.

Autosomal-recessive congenital cerebellar ataxia is caused by mutations in metabotropic glutamate receptor 1.

Guergueltcheva V, Azmanov DN, Angelicheva D, Smith KR, Chamova T, Florez L, Bynevelt M, Nguyen T, Cherninkova S, Bojinova V, Kaprelyan A, Angelova L, Morar B, Chandler D, Kaneva R, Bahlo M, Tournev I,

Am J Hum Genet. 2012 Sep 7;91(3):553-64. doi: 10.1016/j.ajhg.2012.07.019.

Clinical application of next generation sequencing in hereditary spinocerebellar ataxia: increasing the diagnostic yield and broadening the ataxia-spasticity spectrum. A retrospective analysis.

Galatolo D, Tessa A, Filla A, Santorelli FM.

Neurogenetics. 2017 Dec 6. doi: 10.1007/s10048-017-0532-6. [Epub ahead of print] Review.

Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich's Ataxia.

Soragni E, Chou CJ, Rusche JR, Gottesfeld JM.

Front Neurol. 2015 Mar 5;6:44. doi: 10.3389/fneur.2015.00044.

Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia.

Synofzik M, Godau J, Lindig T, Schöls L, Berg D.

Cerebellum. 2011 Mar;10(1):9-13. doi: 10.1007/s12311-010-0215-4.

Mitochondrial dysfunction and oxidative stress contribute to the pathogenesis of spinocerebellar ataxia type 12 (SCA12).

Wang YC, Lee CM, Lee LC, Tung LC, Hsieh-Li HM, Lee-Chen GJ, Su MT.

J Biol Chem. 2011 Jun 17;286(24):21742-54. doi: 10.1074/jbc.M110.160697.

Cerebellar Ataxia and CoQ10 Deficiency.

Quinzii CM, Hirano M, Naini A.

J Neurol Disord Stroke. 2013;1(1):1004. No abstract available.